Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors

摘要

The invention relates to novel betulinic acid derivatives of structural formula having modifications at C2, C3, C17, C20 and/or C29 positions, said derivatives being useful as inhibitors of tumor/cancer cells; process for preparation of the said derivatives; pharmaceutical compositions comprising said derivatives useful in the treatment of ovarian, colon, lung, laryngeal, prostrate cancer, leukemia, lymphoma and a method of treatment of ovarian, colon, lung, laryngeal and prostrate cancer in mammals using said derivatives or compositions.